MannKind Corporation (NASDAQ: MNKD) investors haven’t had much to cheer about lately, with the stock down more than 80 percent in the past three years. However, this week provided investors with a bit of optimism and traders with a huge opportunity for profits.
What Happened?
MannKind shares caught fire this week and are on track to close out the week up more than 140 percent. The move appears to have been triggered by the FDA approving an update to the company’s Afrezza prescribing information to include new study data indicating time-action profiles.
“These data articulate the rapid-acting nature of Afrezza to address post-prandial hyperglycemia, setting it apart from other mealtime options available to help patients maintain greater control over their blood glucose levels,” said Satish Garg, MD, MBBS, DM — Barbara Davis Center for Diabetes (BDC) – University of Colorado, in the company’s press release.
In addition to the positive fundamental news, the stock may have been subject to a short squeeze as well. According to Yahoo Finance, there are more than 21 million shares held short for an elevated short percent of float of 29.7.
Not Everyone Surprised
This week’s huge move on massive volume took MannKind stock as high as $6.51 after it was trading as low as $0.67 back in May. While most Wall Street analysts had left MannKind for dead, Maxim Group initiated coverage with a Buy rating back in August.
“In the U.S., a conservative 5% share of the insulin market is a $350M opportunity,” analyst Jason Kolbert said at the time. “At the current ~$120M market capitalization there is significant upside, in our view.”
Levels To Watch
For now, technical traders will be watching…
Click here to continue reading
Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
